STOCK TITAN

Transaction in Own Shares

Shell (SHEL) purchased shares for cancellation on 5 October 2026 under its existing share buyback programme announced on 30 July 2026.

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Shell (SHEL) purchased shares for cancellation on 5 October 2026 under its existing share buyback programme announced on 30 July 2026. Purchases comprised 825,000 shares on LSE at a volume-weighted average price of £36.1340 per share and 380,000 shares on XAMS at €42.7918 per share. Prices ranged from £35.7950 to £36.3750 on LSE and €42.3550 to €43.1050 on XAMS.

Goldman Sachs International makes trading decisions independently of Shell for the programme period from 30 July through 23 October 2026, within pre-set parameters.

Loading...
Loading translation...

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Transaction in Own Shares

October 05, 2026

• • • • • • • • • • • • • • • •

Shell plc (the 'Company') announces that on 05 October 2026 it purchased the following number of Shares for cancellation.

Aggregated information on Shares purchased according to trading venue:

Date of PurchaseNumber of Shares purchasedHighest price paidLowest price paidVolume weighted average price paid per shareVenueCurrency
05/10/2026825,000£ 36.3750£ 35.7950£ 36.1340LSEGBP
05/10/2026----Chi-X (CXE)GBP
05/10/2026----BATS (BXE)GBP
05/10/2026380,000€ 43.1050€ 42.3550€ 42.7918XAMSEUR
05/10/2026----CBOE DXEEUR
05/10/2026----TQEXEUR

These share purchases form part of the on- and off-market limbs of the Company's existing share buy-back programme previously announced on 30 July 2026. 

In respect of this programme, Goldman Sachs International will make trading decisions in relation to the securities independently of the Company for a period from 30 July 2026 up to and including 23 October 2026.

The on-market limb will be effected within certain pre-set parameters and in accordance with the Company's general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Company's general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 9 of the UK Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes ("EU MAR") and EU MAR as "onshored" into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020)  through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time ("UK MAR") and the Commission Delegated Regulation (EU) 2016/1052 (the "EU MAR Delegated Regulation") and the EU MAR Delegated Regulation as "onshored" into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.

In accordance with EU MAR and UK MAR, a breakdown of the individual trades made by Goldman Sachs International on behalf of the Company as a part of the buy-back programme is detailed below.

Enquiries:

Media International: +44 (0) 207 934 5550; U.S. and Canada: https://www.shell.us/about-us/news-and-insights/media/submit-an-inquiry.html

Attachment


Keep reading